Mylan NV MYL shares are trading lower by $0.80 at $38.15 in Wednesday's session. The issue has come under selling pressure as President-elect Donald Trump has made negative statements on drug pricing during his press conference.
The loss is being magnified since the issue was firmly in the green earlier in today's session. After a higher open, it moved up another $0.03 to $39.58 before reversing course ahead of the comments by Trump. In fact, it was already back at the $39.00 area, when the issue cratered to $37.42 before staging a rebound back into the $38.00 handle.
The current low comes in between its December 29 low ($37.18) and its December 30 low ($37.84). The issue is attempting to avoid its first close under December 29, when it ended that session at $37.38.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
